Acupuncture for Blood Pressure Fluctuation During Total Laparoscopic Hysterectomy

Launched by ILSAN CHA HOSPITAL · Jan 31, 2023

Keywords

ClinConnect Summary

This clinical trial is studying whether acupuncture can help manage blood pressure fluctuations during a surgery called total laparoscopic hysterectomy, which is performed to remove the uterus in women with uterine fibroids. Participants in the trial will receive acupuncture treatment twice before their surgery. Researchers want to find out if this treatment can make blood pressure more stable, especially during critical moments of the surgery.

To be eligible for this trial, participants should be adults aged 19 to 69 who are scheduled for a total laparoscopic hysterectomy by a gynecologist and have a low risk for complications, as measured by their health status. However, individuals with certain health issues, such as severe heart problems or significant bleeding disorders, cannot participate. If you join the study, you can expect to receive acupuncture before your surgery and help researchers learn more about how this treatment might improve surgical experiences for others in the future.

Gender

ALL

Eligibility criteria

• • Adulthood participants who were planned to have surgical removal of uterus for uterine fibroid and have expected date of total laparoscopic hysterectomy by a gynecologist were eligible.
• • Inclusion criteria
• • 1. between age of 19 and 69,
• • 2. American Society of Anesthesiologists (ASA) class I or II,
• • 3. required surgical removal of uterus by a gynecology specialist,
• • 4. scheduled to have total laparoscopic hysterectomy in advance.
• • Exclusion criteria
• • 1. expected survival within 3 months,
• • 2. emergency operation which was not scheduled in advance,
• • 3. hypertension or hypotension that can significantly interfere with the study result,
• • 4. diagnosis of arrhythmia, such as atrial fibrillation, frequent ventricular or supraventricular premature beats,
• • 5. diagnosis of heart failure or valvular disease,
• • 6. anemia of hemoglobin \< 12 g/dL,
• • 7. incapable of surgery due to hemodynamic or medical reasons other than stated above,
• • 8. incapable of receiving acupuncture treatment on determined location,
• • 9. current use of gonadotropin-releasing hormone receptor agonists,
• • 10. current use of drugs that may interfere with the result, including steroids, immunosuppressants, and psychiatric disorders,
• • 11. significant comorbidities that may interfere with the interpretation of intervention efficacy or results, such as stroke, myocardial infarction, kidney disease, dementia, or epilepsy,
• • 12. pregnant, planning to be pregnant within study period, or breastfeeding,
• • 13. previous participation in any other clinical trial within 1 month of participation, planning to participate another clinical trial within 6 months after enrollment date, or planning to participate another clinical trial on follow-up period,
• • 14. fail to write the informed consent form voluntarily,
• • 15. being deemed to be unsuitable for participation.